Douglas Edward Jones Purchases 10,000 Shares of Neogen Co. (NASDAQ:NEOG) Stock

Neogen Co. (NASDAQ:NEOG - Get Free Report) COO Douglas Edward Jones acquired 10,000 shares of Neogen stock in a transaction on Wednesday, April 17th. The shares were bought at an average price of $12.36 per share, for a total transaction of $123,600.00. Following the purchase, the chief operating officer now owns 46,131 shares of the company's stock, valued at $570,179.16. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

Neogen Trading Down 0.2 %

Shares of NASDAQ NEOG opened at $12.14 on Thursday. The stock's 50 day moving average price is $15.61 and its two-hundred day moving average price is $16.58. Neogen Co. has a 52-week low of $11.74 and a 52-week high of $24.09. The stock has a market capitalization of $2.63 billion, a P/E ratio of 1,215.22 and a beta of 1.13. The company has a quick ratio of 2.66, a current ratio of 3.82 and a debt-to-equity ratio of 0.28.

Neogen (NASDAQ:NEOG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). Neogen had a net margin of 0.17% and a return on equity of 3.35%. The firm had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. During the same quarter in the previous year, the company earned $0.12 EPS. The company's quarterly revenue was up 4.8% compared to the same quarter last year. On average, analysts anticipate that Neogen Co. will post 0.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In


The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Click For My #1 FREE Crypto for 2024


Separately, Piper Sandler cut their price target on Neogen from $19.00 to $17.00 and set a "neutral" rating on the stock in a research note on Monday.

Read Our Latest Report on Neogen

Institutional Trading of Neogen

Several institutional investors and hedge funds have recently bought and sold shares of NEOG. Northwest Investment Counselors LLC grew its holdings in Neogen by 1.1% in the 1st quarter. Northwest Investment Counselors LLC now owns 71,621 shares of the company's stock worth $1,130,000 after buying an additional 809 shares in the last quarter. Bridge City Capital LLC boosted its stake in Neogen by 0.8% during the 1st quarter. Bridge City Capital LLC now owns 177,204 shares of the company's stock valued at $2,796,000 after purchasing an additional 1,389 shares in the last quarter. Moody National Bank Trust Division bought a new position in Neogen during the 1st quarter valued at $161,000. Napatree Capital LLC bought a new position in Neogen during the 4th quarter valued at $788,000. Finally, Vanguard Group Inc. boosted its stake in Neogen by 9.3% during the 4th quarter. Vanguard Group Inc. now owns 19,546,737 shares of the company's stock valued at $393,085,000 after purchasing an additional 1,663,125 shares in the last quarter. Institutional investors and hedge funds own 96.73% of the company's stock.

Neogen Company Profile

(Get Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

Featured Articles

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Neogen?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Neogen and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles